Peptide vaccine therapy has already been shown to be safe and useful in the fields of hypertension and diabetes, targeting angiotensin II (AngII) and dipeptidyl peptidase-4 (DPP4), respectively. The gene discussed is DPP4; the disease is diabetes mellitus.